GlassScriptPhysician profile
Christopher J Keary
NPI 1215164041
$21,269.78
in general payments reported to CMS, 2019-2025
4 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,238 · 2024: $1,437 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $771 · Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,060.00 |
| Travel and Lodging | $771.41 |
| Food and Beverage | $200.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ionis Pharmaceuticals, INC. | $13,041.78 | 2025 | |
| Sage Therapeutics, LLC | $4,790.00 | 2024-2025 | |
| Biogen, INC. | $2,238.00 | 2022 | |
| Chiesi USA, INC. | $1,200.00 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Keary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.